Federated Hermes’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.73M | Sell |
654,030
-570,109
| -47% | -$7.61M | 0.02% | 601 |
|
|
2025
Q1 | $12.5M | Buy |
1,224,139
+1,099,519
| +882% | +$11.2M | 0.03% | 507 |
|
|
2024
Q4 | $1.97M | Buy |
+124,620
| New | +$1.97M | ﹤0.01% | 937 |
|
|
2022
Q3 | – | Sell |
-74
| Closed | -$2K | – | 2192 |
|
|
2022
Q2 | $2K | Buy |
+74
| New | +$2K | ﹤0.01% | 1984 |
|
|
2021
Q1 | – | Sell |
-47,703
| Closed | -$3.37M | – | 2293 |
|
|
2020
Q4 | $3.37M | Buy |
+47,703
| New | +$3.37M | 0.01% | 915 |
|